View in EDS

Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Identification of ribosomal protein eL21 as a novel externalized protein and a target in triple-negative breast cancer.
Authors: Arnould L; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Radosevic-Robin N; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France., Duranton L; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Néri J; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France., Penault-Llorca F; Department of Pathology, Centre Jean Perrin, Platform for Advanced/Novel Tissue Analyses (TANYA), University Clermont Auvergne, INSERM U1240, 63011 Clermont-Ferrand, France., Diaz JJ; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France., Albaret MA; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. marie.albaret@lyon.unicancer.fr.; Department of Translational Research and Innovation, Centre Léon Bérard, 69008 Lyon, France. marie.albaret@lyon.unicancer.fr., Catez F; Ribosome, Translation and Cancer team, DevWeCan Labex Laboratory, Institut Convergence PLAsCAN, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69008, Lyon, France. frederic.catez@lyon.unicancer.fr.
Source: Cancer gene therapy [Cancer Gene Ther] 2026 Apr 09. Date of Electronic Publication: 2026 Apr 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5500
DOI:10.1038/s41417-026-01026-7